Blog

May

Dr. Arash Gbayian Discusses Early Detection, Advanced Screening, and the Future of Cancer Care on Persian Radio

Recently, Dr. Arash Gbayian of Beverly Hills Cancer Center joined a special medical radio program hosted by the Southern California Iranian-American Medical Association to discuss one of the most important topics in modern healthcare: early disease detection and the future of per...

Nov

What to Do First If You Find Out You Have Cancer

Taking the Next Steps with Confidence and Care Receiving a cancer diagnosis can feel overwhelming, surprising, and deeply personal. At Beverly Hills Cancer Center (BHCC), we understand both the emotional weight and the urgency you're facing. Our goal is to support you from ...

Mar

The New Therapeutic Imperative in Cancer Management: Sequence, Biosimulate, Treat

The definition of “therapeutic imperative” is this: A treatment necessity that must be met in order to prevent death. Once the imperative is clearly defined, addressing it properly links correct diagnosis with therapy and favorable prognosis. On the other hand, misdia...

Feb

RefleXion Expands Access to SCINTIX Therapy with First Freestanding Cancer Center

RefleXion Expands Access to SCINTIX Therapy with First Freestanding Cancer Center February 10, 2025 10:01 AM Eastern Daylight Time HAYWARD, Calif. --(BUSINESS WIRE)--RefleXion Medical, a theranostic oncology company, today announced the scheduled installation of its RefleXion&r...

Sep

Beverly Hills Cancer Center Blog | Beverly Hills Cancer Center and Deep Lens Partner to Integrate Novel AI-based Clinical Trial Matching Solution VIPER™ Into Practice, Expanding Offering to Patients

Beverly Hills Cancer Center and Deep Lens Partner to Integrate Novel AI-based Clinical Trial Matching Solution VIPER™ Into Practice, Expanding Offering to Patients

Beverly Hills Cancer Center and Deep Lens Partner to Integrate Novel AI-based Clinical Trial Matching Solution VIPER™ Into Practice, Expanding Offering to Patients September 09, 2021 10:05 AM Eastern Daylight Time COLUMBUS, Ohio & LOS ANGELES--(BUSINESS...

Aug

Non-invasive SBRT radiation for early stage lung cancers can be a curative alternative to surgical resection.

Stereotactic Body Radiation Therapy (SBRT) in treating early-stage non-small cell lung cancers (NSCLC) can be considered a safe and effective alternative treatment to surgical resection especially for patients deemed inoperable according to the study reports presented by American...

Aug

Beverly Hills Cancer Center Blog | New short course radiation therapy regimens for prostate cancer instead of the traditional 9 ½ weeks of radiation

New short course radiation therapy regimens for prostate cancer instead of the traditional 9 ½ weeks of radiation

Radiation treatments for prostate cancer have been shown to be highly effective and potentially curative. Radiation therapy has also been shown to be an accepatable alternative to surgery. Short course radiation therapy may be beneficial for patients with low-risk ...

Aug

Cyberknife Surgery – a step ahead in targeted radiotherapy

Cyberknife is a non-invasive frameless robotic radiation surgery used to treat benign or malignant tumors or other medical conditions where radiation therapy is advised. This advanced stereotactic body radiation therapy (SBRT) aims at more précised and targeted therapy del...

Aug

Beverly Hills Cancer Center Rated #1 Radiology Clinic & Imaging Center

Beverly Hills Cancer Center (BHCC) has been rated the #1 radiology and imaging center in expertise and is also ranked among the top 3 clinics in Los Angeles by GCR (Global Clinic Rating). It is indeed a prestigious moment for this progressive cancer clinic that has also been rank...

Aug

Cervical cancer – Today’s awareness leads you to safer tomorrow

Do you know cervical cancer is the 4th most common form of cancer and female cancer-related deaths worldwide? The WHO reports an estimated 528,000 cervical cancer cases in 2012 followed by 266,000 deaths which accounted for 8% of total cancer cases and total cancer deaths. Second ...